REPL's three largest insider shareholders as of March 23, 2026 are Fund Iv, L.P. Omega (TenPercentOwner, 9.44Mn shares), Sushil Patel (Chief Executive Officer, 533.58K shares), Pamela Esposito (Chief Business Officer, 263.44K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Fund Iv, L.P. Omega | 4,673,380 | 4,763,380 | 16 Mar, 2022 | |
| Sushil Patel | Chief Executive Officer | 533,576 | 0 | 19 Dec, 2025 |
| Pamela Esposito | Chief Business Officer | 263,436 | 0 | 13 Sep, 2023 |
| Pamela Esposito | Chief Business Officer | 263,436 | 0 | 13 Sep, 2023 |
| Konstantinos Xynos | Chief Medical Officer | 199,685 | 0 | 19 Dec, 2025 |
| Emily Luisa Hill | Chief Financial Officer | 194,368 | 0 | 19 Dec, 2025 |
| Christopher Sarchi | Chief Commercial Officer | 158,088 | 0 | 19 Dec, 2025 |
| Jean M. Franchi | Chief Financial Officer | 128,748 | 0 | 18 May, 2023 |
| Andrew Schwendenman | Chief Accounting Officer | 78,284 | 0 | 19 Dec, 2025 |
| Andrea Pirzkall | Chief Medical Officer | 21,500 | 0 | 05 Apr, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Dec, 2025 | Konstantinos Xynos | Common Stock | A | 60,000 | $0.00 | 199,685 | D | A |
| 19 Dec, 2025 | Sushil Patel | Common Stock | A | 200,000 | $0.00 | 533,576 | D | A |
| 19 Dec, 2025 | Emily Luisa Hill | Common Stock | A | 60,000 | $0.00 | 194,368 | D | A |
| 19 Dec, 2025 | Andrew Schwendenman | Common Stock | A | 10,000 | $0.00 | 78,284 | D | A |
| 19 Dec, 2025 | Christopher Sarchi | Common Stock | A | 35,000 | $0.00 | 158,088 | D | A |
| 02 Dec, 2025 | Sushil Patel | Common Stock | D | 10,000 | $11.13 | 333,576 | D | S |
| 17 Nov, 2025 | Christopher Sarchi | Common Stock | D | 5,208 | $9.10 | 123,088 | D | S |
| 17 Nov, 2025 | Konstantinos Xynos | Common Stock | D | 7,248 | $9.10 | 139,685 | D | S |
| 15 Aug, 2025 | Emily Luisa Hill | Common Stock | D | 9,154 | $5.37 | 134,368 | D | S |
| 20 May, 2025 | Christopher Sarchi | Common Stock | D | 3,749 | $8.05 | 128,296 | D | S |
| 20 May, 2025 | Andrew Schwendenman | Common Stock | D | 3,287 | $8.05 | 68,284 | D | S |
| 20 May, 2025 | Konstantinos Xynos | Common Stock | D | 7,952 | $8.06 | 146,933 | D | S |
| 20 May, 2025 | Sushil Patel | Common Stock | D | 25,105 | $8.06 | 343,576 | D | S |
| 20 May, 2025 | Emily Luisa Hill | Common Stock | D | 2,535 | $8.05 | 143,522 | D | S |
| 01 Apr, 2025 | Joseph P Slattery | Stock Option (right to buy) | A | 32,000 | $0.00 | 32,000 | D | A |
| 01 Apr, 2025 | Madhavan Balachandran | Stock Option (right to buy) | A | 32,000 | $0.00 | 32,000 | D | A |
| 01 Apr, 2025 | Veleka Peeples-Dyer | Stock Option (right to buy) | A | 32,000 | $0.00 | 32,000 | D | A |
| 01 Apr, 2025 | Christopher Sarchi | Common Stock | A | 45,000 | $0.00 | 132,045 | D | A |
| 01 Apr, 2025 | Konstantinos Xynos | Common Stock | A | 45,000 | $0.00 | 154,885 | D | A |
| 01 Apr, 2025 | Christy J. Oliger | Stock Option (right to buy) | A | 32,000 | $0.00 | 32,000 | D | A |